United States· US:68788-9899_ea0f64e0-dd40-456b-a1f5-2e501ee07e1e
Medroxyprogesterone Acetate
A medroxyprogesterone product containing medroxyprogesterone acetate, registered in United States by Preferred Pharmaceuticals, Inc.. The same ATC class is registered in 8 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Medroxyprogesterone is registered in 8 of 19 countries.
Countries holding a registration under ATC L02AB02 (medroxyprogesterone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Medroxyprogesterone · ATC L02AB02
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of medroxyprogesterone costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Medroxyprogesterone · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.69
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Medroxyprogesterone Acetate
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- L02AB02
- ATC class
- Medroxyprogesterone
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 2
- ndc11687889899110 TABLET in 1 BOTTLE (68788-9899-1)
- ndc11687889899330 TABLET in 1 BOTTLE (68788-9899-3)
Regulatory notes
Interactions
241 interactions on record for medroxyprogesterone.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Medroxyprogesterone · interactions on record
241 records
- 21 severe
- 213 moderate
- 7 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- BosentanC02KX01severe
- GriseofulvinD01AA08severe
- GriseofulvinD01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Medroxyprogesterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMedroxyprogesterone 10mg tabletsPfizer Ltd
- CanadaAA-MEDROXYAA PHARMA INC
- FinlandCykrinaWyeth Medica Ireland
- NetherlandsProvera 10 mg, tablettenEuro Registratie Collectief B.V.
- NorwayProveraPfizer AS
- PolandProveraPfizer Europe MA EEIG
- SwedenProvera 10 mg TablettPfizer AB
- SpainPROGEVERA 10 mg COMPRIMIDOSPfizer S.L.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Depocon, Farlutal
- Belgium · Depo-Provera, Provera
- Bulgaria · Фарлутал
- Czechia · Depo-Provera, Provera
- Germany · Depo-Clinovir, Mpa
- Denmark · Depo-Provera, Provera
- Estonia · Farlutal
- Spain · Depo-Progevera, Progevera
- Finland · Farlutal, Provera
- France · Depo Prodasone, Depo Provera
- United Kingdom (Northern Ireland) · Depo-Provera, Medroxyprogesterone Acetate Pfizer
- Croatia · Provera
- Hungary · Depo-Provera, Provera
- Ireland · Depo-Provera, Provera
- Iceland · Depo-Provera
- Italy · Depo-Provera, Farlutal
- Luxembourg · Depo-Provera, Provera
- Latvia · Depo-Provera
- Netherlands · Depo-Provera, Provera
- Norway · Depo-Provera, Provera
- Poland · Depo-Provera, Provera
- Portugal · Depo-Provera 150
- Sweden · Depo-Provera, Provera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d601b0af-bbe9-462c-9dcf-483f683c20ee GET /v1/drugs/d601b0af-bbe9-462c-9dcf-483f683c20ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "C2QI4IOI2G",
"rxcui": "1000112",
"inchikey": "PSGAAPLEWMOORI-PEINSRQWSA-N",
"display_name": "MEDROXYPROGESTERONE ACETATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 1
},
"spl_meta": {
"1020bb60-4f13-4cd7-aaa1-c556752c84b7": {
"match": "brand_token",
"title": "MEDROXYPROGESTERONE ACETATE TABLET [REMEDYREPACK INC.]",
"spl_version": "1",
"published_date": "2026-05-28"
}
},
"productid": "68788-9899_ea0f64e0-dd40-456b-a1f5-2e501ee07e1e",
"productndc": "68788-9899",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "040159",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "2.5MG",
"product_no": "001",
"approval_date": "Aug 9, 1996"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "5MG",
"product_no": "002",
"approval_date": "Aug 9, 1996"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "10MG",
"product_no": "003",
"approval_date": "Aug 9, 1996"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "MEDROXYPROGESTERONE ACETATE",
"proprietary_name": "Medroxyprogesterone Acetate",
"active_ingred_unit": "mg/1",
"application_number": "ANDA040159",
"marketing_category": "ANDA",
"nonproprietary_name": "Medroxyprogesterone Acetate",
"start_marketing_date": "20120213",
"active_numerator_strength": "10"
}See everything about medroxyprogesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.